Early research (Phase 1)Study completedNCT03894579What this trial is testingAutologous Natural Killer Cells in Subjects With Plaque PsoriasisWho this might be right forPlaque Psoriasis NKGen Biotech, Inc. 9
Large-scale testing (Phase 3)Study completedNCT00096603What this trial is testingEvaluate the Safety of Raptiva in Adults With Plaque Psoriasis Previously Enrolled in Study ACD2600gWho this might be right forPsoriasis Genentech, Inc. 450
Not applicableLooking for participantsNCT04846959What this trial is testingStudy to Evaluate Pregnancy Outcomes in Risankizumab Exposed Pregnancies Relative to Those Non-risankizumab Exposed Pregnancies in Women With FDA Approved IndicationsWho this might be right forPlaque Psoriasis, Psoriatic Arthritis, Crohn's Disease, or Other Conditions for Which Risankizumab is an FDA-approved Treatment AbbVie 818
Post-approval studies (Phase 4)Ended earlyNCT05125679What this trial is testingEffect of Guselkumab on Cardiovascular Risk Surrogate Markers in Participants With Moderate to Severe Plaque PsoriasisWho this might be right forPsoriasis Janssen-Cilag Ltd. 15
Large-scale testing (Phase 3)Study completedNCT03668613What this trial is testingStudy to Assess the Long-term Safety, Tolerability, Efficacy of Secukinumab in Pediatric Patients of Age 6 to <18 Years, With Moderate to Severe Plaque PsoriasisWho this might be right forModerate to Severe Chronic Plaque-type Psoriasis Novartis Pharmaceuticals 84
Testing effectiveness (Phase 2)Study completedNCT03131570What this trial is testingSafety and Efficacy of Secukinumab in Mild PsoriasisWho this might be right forPsoriasis James G. Krueger, MD, PhD 23
Testing effectiveness (Phase 2)Study completedNCT03025542What this trial is testingEvaluate the Pharmacokinetics (PK), Pharmacodynamics (PD), and Safety of Bimekizumab in Patients With Chronic Plaque PsoriasisWho this might be right forChronic Plaque Psoriasis UCB Biopharma SRL 49
Large-scale testing (Phase 3)Ended earlyNCT01163253What this trial is testingA Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque PsoriasisWho this might be right forPsoriasis Pfizer 2,867
Testing effectiveness (Phase 2)Looking for participantsNCT06912165What this trial is testingWD-890 in Participants With Moderate-to-Severe Plaque PsoriasisWho this might be right forBrief Description of Focus of Study Zhejiang Wenda Pharma Technology LTD. 140
Large-scale testing (Phase 3)Study completedNCT02471144What this trial is testingPediatric Study in Children and Adolescents With Severe Plaque PsoriasisWho this might be right forChronic Severe Plaque-type Psoriasis Novartis Pharmaceuticals 162
Very early researchStudy completedNCT05330936What this trial is testingComparison of Cyanocobalamin in Avocado Oil Cream With Steroid Combination OintmentWho this might be right forPlaque Psoriasis Pak Emirates Military Hospital 90
Post-approval studies (Phase 4)Study completedNCT04720105What this trial is testingCombination of Halobetasol Propionate and Tazarotene Lotion (Duobrii®) for Palmoplantar Plaque Type PsoriasisWho this might be right forPalmoplantar PsoriasisPlaque Psoriasis Icahn School of Medicine at Mount Sinai 22
Testing effectiveness (Phase 2)Study completedNCT06073119What this trial is testingEvaluate Efficacy and Safety of SAR441566 in Adults With Plaque PsoriasisWho this might be right forPsoriasis Sanofi 221
Testing effectiveness (Phase 2)Looking for participantsNCT07719530What this trial is testingPhase II Clinical Trial of SHR-1139 Injection in Patients With PsoriasisWho this might be right forPsoriasis Guangdong Hengrui Pharmaceutical Co., Ltd 60
Post-approval studies (Phase 4)Study completedNCT00990561What this trial is testingComparing the Efficacy of Ultravate Ointment in Combination With Lac-Hydrin Lotion in the Treatment of PsoriasisWho this might be right forStable Plaque Psoriasis University of California, San Francisco 40
Not applicableStudy completedNCT00422617What this trial is testingEvaluate the Efficacy and Safety of One Course of Amevive in Taiwan PatientsWho this might be right forChronic Plaque Psoriasis Uni-Pharma 40
Post-approval studies (Phase 4)Study completedNCT00287118What this trial is testingA Multicentre, Open Label Phase IIIb/IV Study of Subcutaneously Administered Raptiva in the Treatment of Adult Subjects With Moderate to Severe Plaque PsoriasisWho this might be right forCandidates for Systemic Therapy for PsoriasisPsoriasis Merck KGaA, Darmstadt, Germany 189
Early research (Phase 1)Study completedNCT03062618What this trial is testingPRCL-02 in Healthy Volunteers and Plaque PsoriasisWho this might be right forPsoriasis PRCL Research Inc. 50
Not applicableStudy completedNCT00769184What this trial is testingCombining Topical Corticosteroid and LCD Treatment for Localized Plaque PsoriasisWho this might be right forPsoriasis NeoStrata Company, Inc. 15
Testing effectiveness (Phase 2)Study completedNCT01622348What this trial is testingTrial of IMO-3100 in Patients With Moderate to Severe Plaque PsoriasisWho this might be right forActively Extending Plaque PsoriasisModerate to Severe Plaque Psoriasis Idera Pharmaceuticals, Inc. 44